Rare Disease
Rare Disease Biotech Announces ‘Hugely Significant’ Milestone with Selection of Candidate Drug
SynaptixBio
PR-06-25-NI-02Jun 10, 2025
Gene Silencing
‘Gene silencing’ therapies market set to boom, says leading biotech
SynaptixBio
PR-11-24-NI-115Nov 20, 2024